Market

Novartis EPS beats by $0.05, revenue in-line; reaffirms guidance



Novartis EPS beats by $0.05, revenue in-line; reaffirms guidance



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.